Product Details:
Payment & Shipping Terms:
|
Starting Materials-1: | Antibody Sequence | Starting Material-2: | Constructed Vectors With Antibody Genes |
---|---|---|---|
Product: | 1-3 Mg Antibody | Purity: | >90% |
Purification Method: | Protein A/G Column | QC: | Sequencing Report |
High Light: | 3mg Antibody Column Antibody Discovery,Protein A G Column Antibody Discovery |
Introduction of Chimeric Antibody Expression
Many monoclonal antibodies are generally produced in mouse that may cause the infamous “Human Anti-Mouse Antibodies” response when used in therapy. The chimeric antibodies are created by fusing variable domains from mouse monoclonal antibodies with human constant domains. Chimeric antibodies do not reduce the affinity or specificity of antibody, and are less easily rejected by the body’s immune system, which are valuable tools for in vivo and in vitro research. With a fully human Fc, chimeric antibodies can also mediate complement-mediated cytotoxicity (CDC) and antibody-dependent cell-mediated cytotoxicity (ADCC).
With a high skilled professional team, CELLFREE has rich experience in providing chimeric antibody expression service. In our service, variable region from any species, such as human, mouse, rabbit, rat, dog and goat, can be combined with any constant domains.
Service Specification
Procedure |
Description |
---|---|
Customers provide |
Customers can provide one of the following two options:
|
Subcloning and transfection |
Antibody genes are constructed into mammalian expression vector, and then transfected into CHO / HEK293 cells. |
Transient expression & |
After transient expression, we can purify 1-3 mg chimeric antibody with purity more than 90% using Protein A/G column. |
QC |
ELISA and western blot is performed for detection. |
Service Content
Custom Provides |
Recombinant Antibody Expression Service |
Deliverables |
Timeline |
Antibody sequences |
|
|
7-9 weeks |
Key Features
No-success no-fee guarantee
Extensive experience
High expression levels
High purity
Low endotoxicity